Andrew Smith has officially opened the new expanded Genzyme facilities at Oxford Business Park.

Genzyme works closely with Oxford University and local hospitals to develop innovative products to help in the treatment of chronically debilitating diseases including genetic disorders, renal disease and thyroid cancer.

Andrew said:  "The growth of Genzyme here in Oxford shows the real benefits of the knowledge economy,  not only generating local jobs but working with our world class university research and NHS hospitals to help relieve the suffering of people with rare and family inherited diseases."